34 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18668909 | System, Devices, and Methods for Time-Resolved Fluorescent Spectroscopy | KIM, KIHO | 2884 | Non-Final OA | May 20, 2024 |
| 18629260 | AUTOMATED NONLINEAR REGISTRATION IN MULTI-MODALITY IMAGING | DANG, DUY M | 2662 | Non-Final OA | Apr 08, 2024 |
| 18580962 | METHODS AND SYSTEMS FOR EARLY DETECTION OF OCULAR AND/OR NEUROLOGICAL CONDITIONS | NG, JONATHAN K | 3619 | Non-Final OA | Jan 19, 2024 |
| 18530467 | COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO TYROSINE KINASE INHIBITORS | KENYON, JOHN S | 1625 | Non-Final OA | Dec 06, 2023 |
| 18386537 | METHODS FOR TREATING NEPHROTIC SYNDROME | HINES, JANA A | 1645 | Final Rejection | Nov 02, 2023 |
| 18288146 | UV A LIGHT EXPOSURE INCREASES MITOCHONDRIAL ANTI-VIRAL PROTEIN EXPRESSION IN TRACHEAL CELLS VIA CELL-TO-CELL COMMUNICATION AND USES THEREOF | SPENCER, ANDREA LYNNE MORRIS | 1631 | Non-Final OA | Oct 24, 2023 |
| 18367154 | DEEP LEARNING-BASED ATTENUATION CORRECTION OF CARDIAC IMAGING DATA | REINIER, BARBARA DIANE | 2682 | Non-Final OA | Sep 12, 2023 |
| 18235945 | ENDOSCOPIC FLUID ASPIRATION DEVICE | YOON, CHANEL J | 3791 | Non-Final OA | Aug 21, 2023 |
| 18447623 | Use of Anti-Il-6 Antibody, e.g., Clazakizumab for Desensitization of Solid Organ Transplant Recipients and/or for Preventing, Stabilizing or Reducing Antibody Mediated Rejection (ABMR) | GAO, ASHLEY HARTMAN | 1678 | Non-Final OA | Aug 10, 2023 |
| 18273161 | COMPOUNDS FOR THE TREATMENT OF A DISEASE OR DISORDER, METHODS FOR IDENTIFYING SAID COMPOUNDS | VASSELL, MEREDITH ABBOTT | 1687 | Non-Final OA | Jul 19, 2023 |
| 18352622 | NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Jul 14, 2023 |
| 18350077 | METHODS AND FORMULATIONS FOR GENE THERAPY, AND FOR COMBINING GENE THERAPY WITH DITPA TREATMENT, OF ALLAN-HERNDON-DUDLEY SYNDROME | BRETZ, COREY LANE | 1635 | Non-Final OA | Jul 11, 2023 |
| 18320653 | Methods for Detecting and Treating Irritable Bowel Syndrome | STOICA, ELLY GERALD | 1647 | Non-Final OA | May 19, 2023 |
| 18161781 | NOVEL BLOOD CELL BIOMARKER FOR LATE ONSET ALZHEIMER'S DISEASE | HALVORSON, MARK | 1646 | Non-Final OA | Jan 30, 2023 |
| 18011589 | PATIENT TRANSFER ASSEMBLY WITH DETACHABLE SUPPORT SURFACE | LAMPRECHT, JOEL | 3798 | Non-Final OA | Dec 20, 2022 |
| 18008146 | TREATMENTS FOR A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS | GOLDBERG, JEANINE ANNE | 1682 | Non-Final OA | Dec 02, 2022 |
| 17998857 | EXOSOME-DERIVED PIWI-INTERACTING RNA AND METHODS OF USE THEREOF | KIM, TAEYOON | 1631 | Final Rejection | Nov 15, 2022 |
| 17986396 | NON-INVASIVE PH-DEPENDENT IMAGING USING QUANTITATIVE CHEMICAL EXCHANGE SATURATION TRANSFER (QCEST) | HANEY, JONATHAN MICHAEL | 3791 | Final Rejection | Nov 14, 2022 |
| 17914050 | BIOMARKER PANELS FOR STRATIFICATION OF RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN CANCER | SALMON, KATHERINE D | 1682 | Final Rejection | Sep 23, 2022 |
| 17912809 | INTERNAL ULTRAVIOLET THERAPY | HOLMES, REX R | 3796 | Non-Final OA | Sep 19, 2022 |
| 17930558 | SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF | MOLOYE, TITILAYO | 1632 | Non-Final OA | Sep 08, 2022 |
| 17796436 | METHOD OF TREATING PANCREATIC CANCER | UNDERDAHL, THANE E | 1699 | Final Rejection | Jul 29, 2022 |
| 17825580 | PREDICTING EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE | MYERS, CARLA J | 1682 | Non-Final OA | May 26, 2022 |
| 17779716 | COMPOSITIONS AND METHODS FOR TREATING DISEASES AND CONDITIONS BY DEPLETION OF MITOCHONDRIAL OR GENOMIC DNA FROM CIRCULATION | AEDER, SEAN E | 1642 | Non-Final OA | May 25, 2022 |
| 17766704 | CORTICAL NEURAL PROGENITOR CELLS FROM IPSCS | HUMPHRIES, NICHOLAS ADAM | 1631 | Final Rejection | Apr 05, 2022 |
| 17766706 | MESH CHOPPING OF NEURAL PROGENITOR CELL AGGREGATES | ABUZEINEH, HANAN ISAM | 1633 | Non-Final OA | Apr 05, 2022 |
| 17639654 | Use of Calcineurin Inhibitor Free CTLA4-IG + Anti-IL6/IL6R For Long Term Immunosuppression in Solid Organ Transplant Recipients | OUSPENSKI, ILIA I | 1644 | Final Rejection | Mar 02, 2022 |
| 17565834 | METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS | FERNANDEZ, SUSAN EMILY | 1651 | Non-Final OA | Dec 30, 2021 |
| 17617878 | SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF | MCLEOD, AFRICA MHAIRIE | 1635 | Final Rejection | Dec 09, 2021 |
| 17435159 | ANTI-CD38 AGENTS FOR DESENSITIZATION AND TREATMENT OF ANTIBODY-MEDIATED REJECTION OF ORGAN TRANSPLANTS | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Aug 31, 2021 |
| 17334109 | METHODS OF STRATIFYING AND TREATING A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS | WHALEY, PABLO S | 3619 | Non-Final OA | May 28, 2021 |
| 17292025 | USE OF CLAZAKIZUMAB TO DESENSITIZE AND IMPROVE RENAL TRANSPLANTATION IN HLA-SENSITIZED PATIENTS | SULLIVAN, DENNIS JOHN | 1642 | Final Rejection | May 07, 2021 |
| 17279259 | METHODS OF TREATING AND DIAGNOSING INFLAMMATORY BOWEL DISEASE | SWIFT, CANDICE LEE | 1657 | Non-Final OA | Mar 24, 2021 |
| 17050067 | METHODS AND SYSTEMS FOR CHARACTERIZING SEVERE CROHN'S DISEASE | MIDDLETON, DANAYA L | 1674 | Non-Final OA | Oct 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial